Danny Sahtoe

Hubrecht Institute for Developmental Biology and Stem Cell Research
Country flagNetherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Protein aggregates are a pathological hallmark across neurodegenerative diseases. Yet, the disconnect between molecular-level aggregation and the emergence of disease severely limits mechanistic understanding of neurodegeneration. Here, we bridge this disconnect by showing that a cellular tipping point emerges as a universal feature across diseases from the competition between aggregate accumulation and removal. We map the resulting cellular phase transition with our high-throughput live-cell assay, measuring the tipping point that separates healthy cells from those with large aggregate loads. Using super-resolution imaging of brain tissue from Alzheimer’s and Parkinson’s disease, we quantify how the balance of accumulation and removal is shifted in disease. We validate our framework by predicting how designed aggregation inhibitors shift the tipping point to restore cellular homeostasis. Our results provide a mechanistic framework connecting molecular-level aggregation to disease, paving the way for a quantitative, unified understanding of neurodegeneration and enabling predictions of therapeutic efficacy.

Year:

2025

Protein design has focused primarily on the design of ground states, ensuring they are sufficiently low energy to be highly populated. Designing the kinetics and dynamics of a system requires, in addition, the design of excited states that are traversed in transitions from one low-lying state to another. This is a challenging task as such states must be sufficiently strained to be poorly populated, but not so strained that they are not populated at all, and because protein design methods have generally focused on creating near-ideal structures. Here we describe a general approach for designing systems which use an induced-fit power stroke to generate a structurally frustrated and strained excited state, allosterically driving protein complex dissociation. X-ray crystallography, double electron-electron resonance spectroscopy, and kinetic binding measurements demonstrate that incorporating excited states enables design of effector-induced increases in dissociation rates as high as 6000-fold. We highlight the power of this approach by designing cytokine mimics which can be dissociated within seconds from their receptors.

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

Tuomas Knowles

1920 Professor of Physical Chemistry

University of Cambridge

UNITED KINGDOM
View details

Shriram Venkatesan

Research Specialist

Stowers Institute for Medical Research

UNITED STATES
View details

David Baker

Professor

University of Washington

UNITED STATES
View details

Stefan Stoll

Professor

University of Washington

UNITED STATES
View details

William A. McEwan

University of Cambridge

UNITED KINGDOM
View details

Daniel Zuckerman

Professor

Oregon Health & Science University

UNITED STATES
View details

Mohamad Abedi

Assistant Professor

University of California, Los Angeles

UNITED STATES
View details

Georg Meisl

Assistant Research Professor

University of Cambridge

UNITED KINGDOM
View details

David Klenerman

University of Cambridge

UNITED KINGDOM
View details

Alain Goriely

University of Oxford

UNITED KINGDOM
View details

Randal Halfmann

Associate Investigator

Stowers Institute for Medical Research

UNITED STATES
View details

Joseph Beckwith

Assistant Professor

University of Warwick

UNITED KINGDOM
View details

Jacob Piehler

Professor of Biophysics

University of Osnabrück

GERMANY
View details